Inhibition of prolylendopeptidase does not affect γ-secretase processing of amyloid precursor protein in a human neuroblastoma cell line

被引:5
作者
Johnston, JA [1 ]
Jensen, M
Lannfelt, L
Walker, B
Williams, CH
机构
[1] Queens Univ Belfast, Ctr Med Biol, Sch Biol & Biochem, Belfast BT9 7BL, Antrim, North Ireland
[2] Karolinska Inst, NEUROTEC Dept, Geriatr Sect, Huddinge, Sweden
关键词
amyloid precursor protein; AP; gamma-secretase; Alzheimer's disease; EC; 3.4.21.26; prolylendopeptidase; neuroblastoma;
D O I
10.1016/S0304-3940(99)00834-4
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
AP peptides are major components of the amyloid plaques that characterize Alzheimer's disease. The enzyme activities (beta- and gamma-secretases) involved in generating AP from amyloid precursor protein (APP) are unidentified. It has been suggested that prolylendopeptidase (PEP), an oligopeptidase that normally cleaves after proline residues, could also cleave after the alanine at position 42 of A beta to generate A beta(42) We investigated whether inhibition of PEP activity in human neuroblastoma cells affected A beta levels in cell culture media. An SH SY5Y cell line expressing SPA4CT, encoding the C-terminal 100 residues of APP and the signal sequence, was used. Only gamma-secretase activity is required for AP production in this cell line. The PEP inhibitor Fmoc-AlaPro-CN (10 mu M) reduced PEP activity in these cells by approximately 95% in the absence of significant toxicity, but had no effect on A beta(40) Or A beta(42) levels in cell culture media. We conclude that PEP is unlikely to be involved in gamma-secretase processing of APP. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:33 / 36
页数:4
相关论文
共 15 条
[1]  
CHECLER F, 1995, J NEUROCHEM, V65, P1431
[2]   EXCESSIVE PRODUCTION OF AMYLOID BETA-PROTEIN BY PERIPHERAL CELLS OF SYMPTOMATIC AND PRESYMPTOMATIC PATIENTS CARRYING THE SWEDISH FAMILIAL ALZHEIMER-DISEASE MUTATION [J].
CITRON, M ;
VIGOPELFREY, C ;
TEPLOW, DB ;
MILLER, C ;
SCHENK, D ;
JOHNSTON, J ;
WINBLAD, B ;
VENIZELOS, N ;
LANNFELT, L ;
SELKOE, DJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (25) :11993-11997
[3]   GENERATION OF BETA-A4 FROM THE AMYLOID PROTEIN-PRECURSOR AND FRAGMENTS THEREOF [J].
DYRKS, T ;
DYRKS, E ;
MONNING, U ;
URMONEIT, B ;
TURNER, J ;
BEYREUTHER, K .
FEBS LETTERS, 1993, 335 (01) :89-93
[4]   Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-β precursor protein and amyloidogenic Aβ peptide formation [J].
Gervais, FG ;
Xu, DG ;
Robertson, GS ;
Vaillancourt, JP ;
Zhu, YX ;
Huang, JQ ;
LeBlanc, A ;
Smith, D ;
Rigby, M ;
Shearman, MS ;
Clarke, FE ;
Zheng, H ;
Van Der Ploeg, LHT ;
Ruffolo, SC ;
Thornberry, NA ;
Xanthoudakis, S ;
Zamboni, RJ ;
Roy, S ;
Nicholson, DW .
CELL, 1999, 97 (03) :395-406
[5]   Analysis of heterogeneous beta A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay [J].
Ida, N ;
Hartmann, T ;
Pantel, J ;
Schroder, J ;
Zerfass, R ;
Forstl, H ;
Sandbrink, R ;
Masters, CL ;
Beyreuther, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (37) :22908-22914
[6]   IDENTIFICATION OF A PUTATIVE AMYLOID A4-GENERATING ENZYME AS A PROLYL ENDOPEPTIDASE [J].
ISHIURA, S ;
TSUKAHARA, T ;
TABIRA, T ;
SHIMIZU, T ;
ARAHATA, K ;
SUGITA, H .
FEBS LETTERS, 1990, 260 (01) :131-134
[7]  
Jensen M, 1999, ANN NEUROL, V45, P504, DOI 10.1002/1531-8249(199904)45:4<504::AID-ANA12>3.0.CO
[8]  
2-9
[9]   INCREASED BETA-AMYLOID RELEASE AND LEVELS OF AMYLOID PRECURSOR PROTEIN (APP) IN FIBROBLAST CELL-LINES FROM FAMILY MEMBERS WITH THE SWEDISH ALZHEIMERS-DISEASE APP670/671 MUTATION [J].
JOHNSTON, JA ;
COWBURN, RF ;
NORGREN, S ;
WIEHAGER, B ;
VENIZELOS, N ;
WINBLAD, B ;
VIGOPELFREY, C ;
SCHENK, D ;
LANNFELT, L ;
ONEILL, C .
FEBS LETTERS, 1994, 354 (03) :274-278
[10]  
Kato A, 1997, J PHARMACOL EXP THER, V283, P328